Why the study?
Does earlier pre-treatment with oral P2Y12-inhibitors improve coronary reperfusion in STEMI patients undergoing primary PCI?
Does earlier pre-treatment with oral P2Y12-inhibitors improve coronary reperfusion in STEMI patients undergoing primary PCI?
Answers are grounded in this paper and cite their sources.
Longer pretreatment with oral P2Y12-inhibitors before primary PCI for STEMI significantly improves angiographic reperfusion and ST resolution.
However, their onset of action is impaired in STEMI and delayed by their oral administration. Angiographic, clinical, and biochemical parameters were evaluated. Pre- and post-pPCI TIMI flow grade (TFG) and ST resolution (STR) were used as outcome measures to determine efficacy and optimal timing of pretreatment. Post-pPCI TFG 3 results also differed significantly between the three groups: 85.2% in Group 0, 88.1% in Group 1, 97.6% in Group 2 (P < 0.013). ST resolution rates were also positively associated with longer pretreatment intervals. CONCLUSIONS: -I administration is time-dependent: longer pretreatment improves coronary reperfusion in terms of pre- and post-pPCI TFG and STR.
No takes yet. Share an insight, caveat, or question.
Pepe et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: